JP2010522240A5 - - Google Patents

Download PDF

Info

Publication number
JP2010522240A5
JP2010522240A5 JP2010501103A JP2010501103A JP2010522240A5 JP 2010522240 A5 JP2010522240 A5 JP 2010522240A5 JP 2010501103 A JP2010501103 A JP 2010501103A JP 2010501103 A JP2010501103 A JP 2010501103A JP 2010522240 A5 JP2010522240 A5 JP 2010522240A5
Authority
JP
Japan
Prior art keywords
tetracycline
compound
composition
inhibitor
tetracycline compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010501103A
Other languages
English (en)
Japanese (ja)
Other versions
JP5395052B2 (ja
JP2010522240A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/057646 external-priority patent/WO2008118744A1/en
Publication of JP2010522240A publication Critical patent/JP2010522240A/ja
Publication of JP2010522240A5 publication Critical patent/JP2010522240A5/ja
Application granted granted Critical
Publication of JP5395052B2 publication Critical patent/JP5395052B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010501103A 2007-03-23 2008-03-20 炎症を処置するための組成物および方法 Expired - Fee Related JP5395052B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89656407P 2007-03-23 2007-03-23
US60/896,564 2007-03-23
PCT/US2008/057646 WO2008118744A1 (en) 2007-03-23 2008-03-20 Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy

Publications (3)

Publication Number Publication Date
JP2010522240A JP2010522240A (ja) 2010-07-01
JP2010522240A5 true JP2010522240A5 (enExample) 2011-03-31
JP5395052B2 JP5395052B2 (ja) 2014-01-22

Family

ID=39651298

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010501103A Expired - Fee Related JP5395052B2 (ja) 2007-03-23 2008-03-20 炎症を処置するための組成物および方法

Country Status (9)

Country Link
US (1) US20080233206A1 (enExample)
EP (1) EP2125018A1 (enExample)
JP (1) JP5395052B2 (enExample)
KR (2) KR20130137696A (enExample)
CN (2) CN102688492A (enExample)
AP (1) AP2657A (enExample)
AU (1) AU2008231033B2 (enExample)
EA (1) EA016206B1 (enExample)
WO (1) WO2008118744A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004261143B2 (en) 2003-07-25 2009-11-05 Allergan Pharmaceuticals International Limited A doxycycline metal complex in a solid dosage form
EP1855690B1 (en) * 2005-01-21 2016-06-01 Warner Chilcott Company, LLC A tetracycline metal complex in a solid dosage form
SG185513A1 (en) * 2010-05-12 2012-12-28 Rempex Pharmaceuticals Inc Tetracycline compositions
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CN103536607A (zh) * 2012-07-10 2014-01-29 邵金辉 土霉素,普罗帕酮和安乃近的抗肿瘤作用
PT106679B (pt) * 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
ITMI20132066A1 (it) * 2013-12-11 2015-06-12 Farmatron Ltd Sistemi terapeutici a rilascio modificato per la somministrazione orale di mentolo nel trattamento delle malattie intestinali
WO2015153864A2 (en) * 2014-04-02 2015-10-08 Hopkins Patricia T Methods for treating inflammatory conditions
CN103933539B (zh) * 2014-04-16 2017-01-11 西北农林科技大学 一种含有四环素的药物组合物及其应用
KR20170134514A (ko) 2015-03-23 2017-12-06 바이오팜엑스 인코포레이티드 피부과 사용을 위한 약학 테트라사이클린 조성물
CN105998037A (zh) * 2016-06-16 2016-10-12 汕头大学 多西环素在制备治疗或预防衰老性疾病的药物中的用途
CO2017001953A1 (es) * 2017-02-27 2018-08-31 Corporacion Univ Lasallista Método de encapsulación de tetraciclinas
DK3873432T3 (da) * 2018-10-29 2022-12-19 Fraunhofer Ges Forschung Tetracyclinkomplekser med vedvarende aktivitet
CN110169973A (zh) * 2019-06-11 2019-08-27 贾树森 一种用于颈椎康复的外用药物组合物
CN111870607A (zh) * 2020-07-09 2020-11-03 温州医科大学 盐酸米诺环素作为制备治疗自身免疫性葡萄膜炎药物的应用及其治疗方法
KR102855121B1 (ko) * 2021-12-17 2025-09-04 주식회사 케이씨앤씨 클로르테트라사이클린을 포함하는 고양이 전염성 복막염 치료용 조성물
CN116655491B (zh) * 2023-05-12 2025-01-28 常州大学 一种多功能抗菌纳米材料TCFNPs及其制备方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736725A (en) * 1954-03-11 1956-02-28 American Cyanamid Co Complexes of tetracycline antibiotics and preparation of same
US2766124A (en) * 1954-05-25 1956-10-09 American Cyanamid Co Antibiotic-containing ice composition
US2806789A (en) * 1954-09-10 1957-09-17 American Cyanamid Co Enhancement of therapeutic efficacy of antibiotics
GB901209A (en) * 1957-10-23 1962-07-18 Pfizer & Co C 6-deoxytetracyclines and compositions containing same
GB901107A (en) * 1959-06-29 1962-07-11 Pfizer Therapeutic composition and method of preparing same
GB894619A (en) * 1959-09-11 1962-04-26 Pfizer & Co C Stabilized liquid preparations comprising tetracycline antibiotics
FR1430859A (enExample) * 1960-05-23 1966-05-25
US3275513A (en) * 1963-05-29 1966-09-27 American Cyanamid Co Stable calcium tetracycline compositions
US4061676A (en) * 1970-07-03 1977-12-06 Ivan Villax Recovery of doxycycline and products thereof
US3957980A (en) * 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
US4060605A (en) * 1973-09-28 1977-11-29 Ankerfarm, S.P.A. Water-soluble derivative of 6-deoxy-tetracyclines
DK153784C (da) * 1973-09-28 1989-01-23 Pfizer Analogifremgangsmaade til fremstilling af 2-n-(methioninomethyl)doxycyclin eller salte deraf
US4150111A (en) * 1974-05-28 1979-04-17 Allister Warren Enteric coated magnesium chloride
JPS51107134A (en) * 1975-03-17 1976-09-22 Asahi Optical Co Ltd Shotenmenkenshutsusochi
US4081527A (en) * 1976-12-07 1978-03-28 Pfizer Inc. Chlortetracycline compositions
US4126680A (en) * 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5250442A (en) * 1993-04-08 1993-10-05 Orestes Cabezas Method of treating rheumatoid arthritis using tetracycline
US5538954A (en) * 1994-06-24 1996-07-23 A/S Dumex (Dumex Ltd.) Salts of tetracyclines
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
EP0834321B1 (en) * 1995-06-13 2003-05-02 Nippon Meat Packers, Inc. Oral remedy for rheumatoid arthritis and functional food
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5968896A (en) * 1998-01-16 1999-10-19 Beth Israel Deaconess Medical Center Nutritional supplement for preoperative feeding
EP1152709B1 (en) * 1999-02-02 2005-01-12 Wright Medical Technology, Inc. Controlled release composite
US7884090B2 (en) * 1999-03-17 2011-02-08 Ernest L. Bonner, Jr. Compositions and methods for the treatment of arthritis
US6765000B2 (en) * 1999-03-17 2004-07-20 Bonner Jr Ernest L Treatment for reactive arthritis or bursitis
US6946118B1 (en) * 1999-09-14 2005-09-20 Orapharma, Inc. Formulations for treating or preventing mucositis
US6638532B2 (en) * 2000-02-24 2003-10-28 Advancis Pharmaceutical Corp. Tetracycline—doxycycline antibiotic composition
US6887492B2 (en) * 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
DE60212613T2 (de) * 2001-04-05 2007-05-24 Collagenex Pharmaceuticals, Inc. Doxycyclin zur behandlung von akne
US7211267B2 (en) * 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
WO2002089743A2 (en) * 2001-05-09 2002-11-14 The Regents Of The University Of Michigan Use of compositions for treating rosacea
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
US7122578B2 (en) * 2001-09-11 2006-10-17 Alain Martin Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration
NO315915B1 (no) * 2002-02-25 2003-11-10 Sintef Elektronikk Og Kybernet Fj¶rvekt
JP2005533766A (ja) * 2002-05-20 2005-11-10 コッラジェネックス ファーマシューチカルス インコーポレイテッド アレルギー反応の治療方法
AU2004261143B2 (en) * 2003-07-25 2009-11-05 Allergan Pharmaceuticals International Limited A doxycycline metal complex in a solid dosage form
EP2284152A3 (en) * 2004-10-25 2011-10-05 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP1855690B1 (en) * 2005-01-21 2016-06-01 Warner Chilcott Company, LLC A tetracycline metal complex in a solid dosage form
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne

Similar Documents

Publication Publication Date Title
JP2010522240A5 (enExample)
JP6843930B2 (ja) ニトロカテコールの投与計画
HRP20192133T1 (hr) Kemijski spoj koristan kao posrednik za pripremu inhibitora katekol-o-metiltransferaze
JP2014526503A5 (enExample)
JP2011068653A5 (enExample)
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
JP2006143751A5 (enExample)
JP2016534063A5 (enExample)
RU2014115287A (ru) Фармацевтическая композиция для перорального введения с маскированным вкусом и способ ее получения
HRP20151021T1 (hr) Formulacije na osnovi nalbufina i njihove uporabe
JP2012533565A5 (enExample)
JP2012236834A5 (enExample)
CA2967424C (en) Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone
JP2014527506A5 (enExample)
US10758528B2 (en) Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, prodrugs, methods of making and use thereof
JP2021502382A5 (enExample)
CA2964684A1 (en) Composition for the treatment of conditions involving muscular pain
JP2014509637A5 (enExample)
JP2017530182A5 (enExample)
AU2012311964B2 (en) Buffered upper GI absorption promoter
JP2017526719A5 (enExample)
JP2014530200A5 (enExample)
JP2009503072A5 (enExample)
RU2021124928A (ru) Соединения для применения при лечении или профилактики боли, воспаления и/или аутоиммунной реакции
JP2008540591A5 (enExample)